Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-15 · accession 0001601830-24-000213 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | RXRX | Marriott Tina | Pres, COO | F - Tax | $6.18 | -14.3K | 506.9K | -3% | -$88.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-15 | F | D | 14,286 | $6.18 | 506,852 | D | — | — |